D-0679-2017 Class III Terminated
FDA drug recall D-0679-2017 was initiated by Novartis Pharmaceuticals Corp. on Mar 22, 2017 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications. The recall status is terminated (terminated Feb 5, 2020).
Recall details
- Product Type
- Drugs
- Report Date
- May 3, 2017
- Initiation Date
- Mar 22, 2017
- Termination Date
- Feb 5, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Pilocarpine Hydrochloride Ophthalmic Solution 4% , packaged in 15 mL bottles, Rx Only, Manufactured by Alcon Laboratories, Inc. Fort Worth, Texas 76134 Sandoz Princeton, NJ 08540, NDC 61314-206-15
Reason for recall
Failed Impurities/Degradation Specifications.
Distribution pattern
nationwide
Code information
Lot #: 244660F, Exp. FEB 2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0679-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026